Please login to the form below

Not currently logged in
Email:
Password:

Ad26

This page shows the latest Ad26 news and features for those working in and with pharma, biotech and healthcare.

HIV vaccine from J&J starts human trials

HIV vaccine from J&J starts human trials

In the case of J&J's vaccine, the regimen is an adenovirus serotype 26 (Ad26) vectored vaccine to prime the immune system, followed by a boost with a purified HIV

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics